Influenza Vaccine

IDT sees big potential in vaccine contracting

IDT sees big potential in vaccine contracting

By Gareth Macdonald and Claire Videau

IDT Biologika.says demand for vaccines in emerging markets is big chance for Big Pharma and hence a growing niche for contractors with the technical capabilities to carry out such work.

Zydus begins H1N1 trials

Zydus begins H1N1 trials

By Nick Taylor

Zydus Cadila has become the first Indian pharma company to begin multi-centre clinical trials of a H1N1 vaccine after it received approval from the Drug Controller General of India (DCGI).

West laying off 100 staff

West laying off 100 staff

By Nick Taylor

West Pharmaceutical Services is laying off 100 staff as part of restructuring efforts after its third quarter results fell short of expectations, despite operating profit increasing by 45 per cent.

Novartis comments on $490m cell-culture vaccine contract

Novartis comments on $490m cell-culture vaccine contract

By Gareth Macdonald

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers